Approval · Notice of Compliance 559 · 2002
PUREGON: Notice of Compliance 559
Issued October 10, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 559
- Date
- October 10, 2002
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Alternate manufacturing site
- Therapeutic class
- Human gonadotropin
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PUREGON | Not yet assigned | — |
Medicinal ingredients
- FOLLITROPIN BETA 50 UNIT per VIAL
- FOLLITROPIN BETA 75 UNIT per VIAL
- FOLLITROPIN BETA 100 UNIT per VIAL
- FOLLITROPIN BETA 150 UNIT per VIAL
- FOLLITROPIN BETA 200 UNIT per VIAL
- FOLLITROPIN BETA 225 UNIT per VIAL
- FOLLITROPIN BETA 250 UNIT per VIAL